CNA vs RARE · P/E 10, rev $7.51B vs rev $350.0M
CNA Financial Corporation (CNA) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
CNA Financial Corporation (CNA) is a insurance - property & casualty company listed on NYSE.
Ultragenyx (RARE) is a biotechnology company listed on US.
Latest reported CNA revenue for 2026-06-30 was $7.51B. Net income was $532.0M. CNA currently screens at market cap $12.25B and trailing P/E 10.1.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
CNA currently screens at market cap $12.25B and trailing P/E 10.1. RARE currently screens at market cap $2.79B.
Not investment advice. Open the CNA and RARE stock pages for the full models.
Not investment advice.